2-Substituted-3-(5-Substituted-1,3,4-oxadiazol/thiadiazol-2-yl) Thiazolidin-4-one Derivatives: Synthesis, Anticancer, Antimicrobial, and Antioxidant Potential.

1,3,4-oxadiazole 1,3,4-thiadiazole anticancer antimicrobial activity antioxidant potential synthesis thiazolidin-4-one

Journal

Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453

Informations de publication

Date de publication:
29 May 2023
Historique:
received: 20 03 2023
revised: 20 05 2023
accepted: 22 05 2023
medline: 28 6 2023
pubmed: 28 6 2023
entrez: 28 6 2023
Statut: epublish

Résumé

In this innovative research, a novel series of thiazolidin-4-one analogues having a 1,3,4-oxadiazole/thiadiazole moiety were derived and the structures of all the newly obtained molecules were established using different physicochemical and analytical means (

Identifiants

pubmed: 37375752
pii: ph16060805
doi: 10.3390/ph16060805
pmc: PMC10305112
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : King Saud University, Riyadh, Saudi Arabia
ID : Researchers Supporting Project number (RSP2023R491)

Références

Front Microbiol. 2019 Sep 12;10:2130
pubmed: 31572335
J Org Chem. 2015 Jan 16;80(2):1018-24
pubmed: 25506709
Scientifica (Cairo). 2022 Apr 8;2022:3011531
pubmed: 35433072
Molecules. 2021 Oct 30;26(21):
pubmed: 34770996
Curr Drug Res Rev. 2021;13(2):90-100
pubmed: 33349230
Evid Based Complement Alternat Med. 2022 Aug 17;2022:3290790
pubmed: 36034950
Prim Care. 2018 Sep;45(3):467-484
pubmed: 30115335
Eur J Med Chem. 2010 Jul;45(7):2806-16
pubmed: 20347509
Pharmaceuticals (Basel). 2023 Mar 30;16(4):
pubmed: 37111274
Molecules. 2021 Aug 25;26(17):
pubmed: 34500593
Front Chem. 2022 Jan 21;9:671212
pubmed: 35127639
Pharmaceuticals (Basel). 2023 Feb 07;16(2):
pubmed: 37259401
Molecules. 2022 Oct 10;27(19):
pubmed: 36235304
Chem Biol Drug Des. 2022 Dec;100(6):1086-1121
pubmed: 35676800
BMC Chem. 2022 Aug 17;16(1):61
pubmed: 35978438
Eur J Med Chem. 2019 Mar 1;165:18-30
pubmed: 30654237
PLoS One. 2008;3(12):e4036
pubmed: 19112501
Chem Biol Drug Des. 2013 May;81(5):557-76
pubmed: 23452185
Int J Mol Sci. 2021 Jun 29;22(13):
pubmed: 34209520
Pharm Stat. 2011 Mar-Apr;10(2):128-34
pubmed: 22328315
Front Oncol. 2022 Apr 06;12:852927
pubmed: 35463300

Auteurs

Davinder Kumar (D)

Department of Pharmaceutical Sciences, Maharishi Dayanand University, Rohtak 124001, India.

Navidha Aggarwal (N)

MM College of Pharmacy, Maharishi Markandeshwar (Deemed to Be University), Mullana 133207, India.

Harsh Kumar (H)

Department of Pharmaceutical Sciences, Maharishi Dayanand University, Rohtak 124001, India.

Garima Kapoor (G)

KIET School of Pharmacy, KIET Group of institution Delhi-NCR, Ghaziabad 201206, India.

Aakash Deep (A)

Department of Pharmaceutical Sciences, Chaudhary Bansi Lal University, Bhiwani 127021, India.

Shabana Bibi (S)

Department of Biosciences, Shifa Tameer-e-Millat University, Islamabad 41000, Pakistan.
Yunnan Herbal Laboratory, College of Ecology and Environmental Sciences, Yunnan University, Kunming 650091, China.

Aastha Sharma (A)

Department of Pharmaceutical Sciences, Maharishi Dayanand University, Rohtak 124001, India.

Hitesh Chopra (H)

Chitkara College of Pharmacy, Chitkara University, Punjab 140401, India.

Rakesh Kumar Marwaha (R)

Department of Pharmaceutical Sciences, Maharishi Dayanand University, Rohtak 124001, India.

Abdulrahman Alshammari (A)

Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.

Metab Alharbi (M)

Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.

Abdul Hayee (A)

Department of Immunology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama 930-0194, Japan.

Classifications MeSH